Suppr超能文献

新型冠状病毒肺炎重症监护病房中由鲍曼不动杆菌引起的社区获得性肺炎导致的快速传播和高死亡率。

Rapid spread and high mortality due to community-acquired pneumonia caused by (CAP-AB) in a Covid-19 intensive care unit.

作者信息

Shafigh Navid, Roodneshin Fatemeh, Shafigh Elnaz, Kermany Mahtab Poor Zamany Nejat, Ziaie Shadi, Miller James, Gharehbeglou Mohammad, Masoumzadeh Niyoosha, Hasheminik Morteza, Avval Jamshid Ordoni

机构信息

Department of Anesthesiology and Critical Care Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Operative, Faculty of Dentistry, AJA University of Medical Science, Tehran, Iran.

出版信息

J Family Med Prim Care. 2022 Dec;11(12):7957-7959. doi: 10.4103/jfmpc.jfmpc_1117_22. Epub 2023 Jan 17.

Abstract

is a rare but dangerous gram-negative bacteria causing nosocomial infections, especially in intensive care units. The increased use of antibiotics in the treatment of bacterial infections leads to drug resistance, delays, or failures in treatment. The patient is a 48-year-old man with coronavirus disease (COVID-19) being treated in the intensive care unit. After contracting , the patient's condition deteriorated, and he developed severe pulmonary problems. Due to the unknown presence of in the patient, this bacterium transmitted to six other patients in the ward, which resulted in their deaths. In this report, we describe the causes and risk factors of the disease, and the results of laboratory tests and therapeutic processes.

摘要

是一种罕见但危险的革兰氏阴性菌,可引起医院感染,尤其是在重症监护病房。在治疗细菌感染中抗生素使用的增加导致耐药性、治疗延误或治疗失败。该患者是一名48岁的患有冠状病毒病(COVID-19)的男性,正在重症监护病房接受治疗。感染 后,患者病情恶化,并出现严重的肺部问题。由于患者体内未知的 存在,这种细菌传播到病房的其他六名患者身上,导致他们死亡。在本报告中,我们描述了该疾病的病因和危险因素,以及实验室检查结果和治疗过程。

你提供的原文中存在一些未明确的细菌名称(用 表示),请确认准确内容以便译文更准确。

相似文献

1
Rapid spread and high mortality due to community-acquired pneumonia caused by (CAP-AB) in a Covid-19 intensive care unit.
J Family Med Prim Care. 2022 Dec;11(12):7957-7959. doi: 10.4103/jfmpc.jfmpc_1117_22. Epub 2023 Jan 17.
3
A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea.
Infect Chemother. 2017 Dec;49(4):297-300. doi: 10.3947/ic.2017.49.4.297.
4
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.
Infection. 2022 Feb;50(1):83-92. doi: 10.1007/s15010-021-01643-4. Epub 2021 Jun 27.
5
[Drug resistance of in pediatric intensive care unit].
Zhonghua Er Ke Za Zhi. 2021 Aug 2;59(8):651-657. doi: 10.3760/cma.j.cn112140-20210117-00053.
6
Community acquired multi drug resistant (MDR) pneumonia in Malaysia - A case report.
Respir Med Case Rep. 2018 May 17;24:147-149. doi: 10.1016/j.rmcr.2018.05.019. eCollection 2018.

本文引用的文献

3
Hospital infection control programs: assessment of process and structure indicators.
Rev Esc Enferm USP. 2018 Aug 6;52:e03364. doi: 10.1590/S1980-220X2017039903364.
4
Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
J Microbiol Immunol Infect. 2018 Oct;51(5):629-635. doi: 10.1016/j.jmii.2017.02.004. Epub 2017 Jun 29.
5
Carbapenem-resistant Acinetobacter baumannii contamination in an intensive care unit.
Rev Soc Bras Med Trop. 2017 Mar-Apr;50(2):167-172. doi: 10.1590/0037-8682-0329-2016.
6
Impact of Contact Isolation Precautions on Multi-Drug Resistant Acinetobacter baumannii in the Pediatric Intensive Care Unit.
Infect Control Hosp Epidemiol. 2015 Sep;36(9):1108-10. doi: 10.1017/ice.2015.140. Epub 2015 Jun 5.
7
A Review of the CDC Recommendations for Prevention of HAIs in Outpatient Settings.
AORN J. 2015 May;101(5):519-25; quiz 526-8. doi: 10.1016/j.aorn.2015.02.007.
8
Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections.
Int J Infect Dis. 2013 Oct;17(10):e802-5. doi: 10.1016/j.ijid.2013.03.021. Epub 2013 May 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验